A01=Bita Moghaddam
Age Group_Uncategorized
Age Group_Uncategorized
american literature
anxiety and depression
art
Author_Bita Moghaddam
automatic-update
bioscience
business
Category1=Non-Fiction
Category=JM
classic
consciousness
COP=United States
Delivery_Delivery within 10-20 working days
depression
depression books
drugs
economics
eq_bestseller
eq_isMigrated=2
eq_nobargain
eq_non-fiction
eq_society-politics
essay
essays
gifts for doctors
gifts for students
health
human nature
internet
journalism
Language_English
medical books
medicine
medicine books
mental health
mental health books
mental illness
mental illness books
neuropsychology
PA=Available
philosophy
Price_€10 to €20
PS=Active
psychiatry
psychiatry books
psychology
psychology book
psychology books
science gifts
sociology
softlaunch
special k
suspense
thriller
wellness
Product details
- ISBN 9780262542241
- Dimensions: 127 x 178mm
- Publication Date: 16 Feb 2021
- Publisher: MIT Press Ltd
- Publication City/Country: US
- Product Form: Paperback
- Language: English
Secure
checkout
Fast Shipping
Easy returns
The emergence of ketamine--previously known as a combat anesthetic and club drug--as a treatment for depression.
Ketamine, approved in 2019 by the Food and Drug Administration for the treatment of depression, has been touted by scientists and media reports as something approaching a miracle cure. This volume in the MIT Press Essential Knowledge series chronicles the ascent of a drug that has been around for fifty years--in previous incarnations, a Vietnam-era combat anesthetic and a popular club drug--that has now been reinvented as a treatment for depression. Bita Moghaddam, a leading researcher in neuropharmacology, explains the scientific history and the biology of ketamine, its clinical use, and its recently discovered antidepressant effects, for the nonspecialist reader.
Ketamine, approved in 2019 by the Food and Drug Administration for the treatment of depression, has been touted by scientists and media reports as something approaching a miracle cure. This volume in the MIT Press Essential Knowledge series chronicles the ascent of a drug that has been around for fifty years--in previous incarnations, a Vietnam-era combat anesthetic and a popular club drug--that has now been reinvented as a treatment for depression. Bita Moghaddam, a leading researcher in neuropharmacology, explains the scientific history and the biology of ketamine, its clinical use, and its recently discovered antidepressant effects, for the nonspecialist reader.
Bita Moghaddam is a leading researcher in the field of neuropsychopharmacology. She is Ruth Matarazzo Professor of Behavioral Neuroscience at Oregon Health and Science University in Portland.
